SCHEMBL29853136

SCHEMBL29853136

Cc1oc2ccc(Br)cc2c1CO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.47
PIM1 P11309 1/20 0.44
CASP6 P55212 1/20 0.43
RAB9A P51151 4/20 0.43
NPC1 O15118 3/20 0.43
CA12 O43570 2/20 0.41
CA9 Q16790 2/20 0.41
MAPT P10636 4/20 0.40
LMNA P02545 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
SLC26A4 O43511 1/20 0.39
BLM P54132 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23218435 1.00 KCNH2 (0.47) KCNH2PIM1CASP6RAB9ANPC1
SCHEMBL23218349 0.81 PIM1 (0.49) KCNH2PIM1CASP6RAB9ANPC1
SCHEMBL23218086 0.80 PIM1 (0.45) KCNH2PIM1CASP6RAB9ANPC1
SCHEMBL23218211 0.80 KCNH2 (0.42) KCNH2PIM1CASP6RAB9ANPC1
SCHEMBL29852587 0.80 PIM1 (0.45) KCNH2PIM1CASP6RAB9ANPC1
SCHEMBL29853267 0.80 KCNH2 (0.42) KCNH2PIM1CASP6RAB9ANPC1
SCHEMBL3894812 0.80 CDK9 (0.50) KCNH2PIM1CASP6RAB9ANPC1
SCHEMBL10857787 0.79 KCNH2 (0.50) KCNH2PIM1CASP6RAB9ANPC1
SCHEMBL23218877 0.79 KCNH2 (0.41) KCNH2PIM1CASP6RAB9ANPC1
SCHEMBL23218189 0.78 PIM1 (0.43) KCNH2PIM1CASP6RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4041238-A1 ORAL COMPLEMENT FACTOR D INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2022-08-17 EP disclosed